Recent developments in Massachusetts’ biotech sector highlight a significant recovery and growth phase, with the industry contributing approximately $42 billion to the state’s economy in 2024. Following a downturn in 2021 and 2022, biotech is now entering what experts call the eighth “up cycle” since its inception. Notable statistics from the first half of 2026 include a 25% increase in venture funding, amounting to $3.45 billion, and major acquisitions totaling $18 billion, contrasting sharply with last year’s figures. Companies like Moderna, despite recent layoffs, saw their stock nearly triple after promising trial results for a new personalized mRNA vaccine. Overall, optimism is widespread, with experts urging continued support for Massachusetts’ biotech ecosystem, which has received a $1 billion funding commitment from the state government over the next decade.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.bostonglobe.com/2026/08/25/business/massachusetts-lost-biotech-jobs-first-time-2025-new-report-shows/?p1\u003dSectionFront_Feed_AuthorQuery
